Invention Grant
US08192945B2 Method for screening compounds to determine those which enhance islet cell activity and/or survival and uses therefor
有权
筛选化合物以确定增强胰岛细胞活性和/或存活及其用途的化合物的方法
- Patent Title: Method for screening compounds to determine those which enhance islet cell activity and/or survival and uses therefor
- Patent Title (中): 筛选化合物以确定增强胰岛细胞活性和/或存活及其用途的化合物的方法
-
Application No.: US12340484Application Date: 2008-12-19
-
Publication No.: US08192945B2Publication Date: 2012-06-05
- Inventor: Marc R. Montminy
- Applicant: Marc R. Montminy
- Applicant Address: US CA La Jolla
- Assignee: The Salk Institute for Biological Studies
- Current Assignee: The Salk Institute for Biological Studies
- Current Assignee Address: US CA La Jolla
- Agency: Klarquist Sparkman, LLP
- Main IPC: G01N33/567
- IPC: G01N33/567

Abstract:
In accordance with the present invention, it has been discovered that glucose and incretin hormones promote pancreatic islet cell survival via the calcium and cAMP dependent induction, respectively, of the transcription factor CREB. Specifically, a signaling module has been identified which mediates cooperative effects of calcium and cAMP on islet cell gene expression by stimulating the dephosphorylation and nuclear entry of TORC2, a cytoplasmic CREB coactivator. These findings provide a novel mechanism by which CREB activates cellular gene expression, depending on nutrient and energy status, and facilitate development of assays to identify compounds which modulate the role of TORCs.
Public/Granted literature
- US20100190693A1 METHOD FOR SCREENING COMPOUNDS & USES THEREFOR Public/Granted day:2010-07-29
Information query
IPC分类: